Skip to main content

Neonatal renal vein thrombosis and prothrombotic risk

Buy Article:

$51.00 plus tax (Refund Policy)


A case of extensive deep venous thrombosis in a four a day old infant was presented. Unusually this patient was shown to be heterozygous for three thrombophilia genes; Factor V Leiden, prothrombin and antithrombin gene mutations, the latter being novel. Conclusion: 

There are no randomized controlled trials to guide management in deep venous thrombosis in the newborn but knowledge of the prothrombotic risk factors may help direct treatment.
No References
No Citations
No Supplementary Data
No Data/Media
No Metrics

Keywords: Antithrombin gene mutation; Low molecular weight heparin; Newborn infant; Prothrombotic risk factors; Renal vein thrombosis

Document Type: Research Article

Affiliations: 1: Neonatal Unit, Christchurch Women's Hospital, Christchurch, New Zealand 2: Department of Haematology, Canterbury District Health Board, Christchurch, New Zealand 3: Canterbury Health Laboratories, Christchurch, New Zealand 4: Department of Paediatrics, Christchurch School of Medicine, University of Otago, Christchurch, New Zealand

Publication date: 2010-07-01

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more